RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 118 filers reported holding RELMADA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $839,281,000 | +226.7% | 22,671 | +67.6% | 0.00% | – |
| Q2 2022 | $256,916,000 | -60.5% | 13,529 | -43.9% | 0.00% | – |
| Q1 2022 | $650,999,000 | +176.4% | 24,120 | +227.8% | 0.00% | – |
| Q2 2021 | $235,530,000 | +4.5% | 7,358 | +15.0% | 0.00% | – |
| Q1 2021 | $225,344,000 | +9.8% | 6,400 | 0.0% | 0.00% | – |
| Q4 2020 | $205,248,000 | -54.2% | 6,400 | -46.2% | 0.00% | – |
| Q3 2020 | $447,678,000 | +81.9% | 11,900 | +116.4% | 0.00% | – |
| Q2 2020 | $246,125,000 | – | 5,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Guild Investment Management, Inc. | 205,300 | $615,900 | 1.03% |
| Deep Track Capital, LP | 2,837,818 | $8,513,454 | 0.33% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 974,082 | $2,922,246 | 0.23% |
| apricus wealth, LLC | 77,362 | $239,822 | 0.21% |
| Palo Alto Investors LP | 732,400 | $2,197,200 | 0.21% |
| RTW INVESTMENTS, LP | 2,131,835 | $6,395,505 | 0.14% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $300,000 | 0.09% |
| AdvisorShares Investments LLC | 112,908 | $338,724 | 0.09% |
| Savior LLC | 3,500 | $10,500 | 0.07% |
| Spotlight Asset Group, Inc. | 20,000 | $60,000 | 0.05% |